医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
28期
73-74
,共2页
非萎缩性胃炎%兰索拉唑%健胃愈疡胶囊%临床疗效
非萎縮性胃炎%蘭索拉唑%健胃愈瘍膠囊%臨床療效
비위축성위염%란색랍서%건위유양효낭%림상료효
non-atrophic gastritis%lansoprazole%Jianwei Yuyang capsule%clinical effect
目的观察健胃愈疡胶囊联合兰索拉唑和氢氧化铝对慢性非萎缩性胃炎的临床疗效。方法86例胃镜和病理证实的慢性非萎缩性胃炎,随机分为西药组服兰索拉唑和氢氧化铝,中西医组加服健胃愈疡胶囊。治疗4周后观察临床症状、血细胞分析、C反应蛋白(CRP)、复查胃镜和病理变化。结果两组患者治疗后临床症状、血生化指标及胃镜和病理结果改善明显,总有效率分别地为90.7%和97.67%( Z=-2.168,P=0.03)。结论健胃愈疡胶囊联合索拉唑和氢氧化铝治疗慢性非萎缩性胃炎临床疗效确切,值得临床推广。
目的觀察健胃愈瘍膠囊聯閤蘭索拉唑和氫氧化鋁對慢性非萎縮性胃炎的臨床療效。方法86例胃鏡和病理證實的慢性非萎縮性胃炎,隨機分為西藥組服蘭索拉唑和氫氧化鋁,中西醫組加服健胃愈瘍膠囊。治療4週後觀察臨床癥狀、血細胞分析、C反應蛋白(CRP)、複查胃鏡和病理變化。結果兩組患者治療後臨床癥狀、血生化指標及胃鏡和病理結果改善明顯,總有效率分彆地為90.7%和97.67%( Z=-2.168,P=0.03)。結論健胃愈瘍膠囊聯閤索拉唑和氫氧化鋁治療慢性非萎縮性胃炎臨床療效確切,值得臨床推廣。
목적관찰건위유양효낭연합란색랍서화경양화려대만성비위축성위염적림상료효。방법86례위경화병리증실적만성비위축성위염,수궤분위서약조복란색랍서화경양화려,중서의조가복건위유양효낭。치료4주후관찰림상증상、혈세포분석、C반응단백(CRP)、복사위경화병리변화。결과량조환자치료후림상증상、혈생화지표급위경화병리결과개선명현,총유효솔분별지위90.7%화97.67%( Z=-2.168,P=0.03)。결론건위유양효낭연합색랍서화경양화려치료만성비위축성위염림상료효학절,치득림상추엄。
Objective To observe the clinical effect of Jianwei Yuyang capsule combined with lansoprazole and aluminum hydroxide on the treatment of chronic non-atrophic gastritis(CNAG). Methods Eighty six patients with CNAG were col ected and randomly divided into Western medicine group and combination treatment group, the former group were given lansoprazole and aluminum hydroxide, the latter group were given Jianwei Yuyang capsule plus. The clinical symptoms, blood cellanalysis, C reactive protein contents, gastroscopy and pathological changes were observed. Results The clinical symptoms, blood biochemical indexes, gastroscopy and pathology results were improved significantly after treatment, the total effective rates in Western medicine group and combination treatment group were 90.7% and 97.67% (Z=-2.168, P=0.03) respectively. Conclusion The combination therapy of Jianwei Yuyang capsule combined with lansoprazole and aluminum hydroxide had a exactly clinical curative effect in the treatment of CNAG, which is worth of generalization in clinic.